Turkey

Turkey's drug market is attracting the attention of global investors after growing by 33% in 2005. US drugmaker Valeant is planning to launch its neurological products, while Sandoz... 2006-04-12

According to new data from IMS Health, prescription pharmaceutical sales in Turkey soared 54% in 2005 - outstripping a 20% gain in Russia and a 15% rise in South Korea. Although the... 2006-03-30

Turkish drugmaker Eczacibasi Pharmaceuticals has recently opened a new US$4mn antibiotics facility, which will specialise in the production of cephalosporin. Eczacibasi Pharmaceuticals... 2006-03-22

Generics maker Sandoz, a division of Swiss drugmaker Novartis, has re-entered the Turkish market after an absence of more than a decade. When Novartis acquired German generics firm... 2006-03-01